Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Q4 2025 Earnings Call Transcript February 27, 2026
Amneal Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $0.108 EPS, expectations were $0.18.
Operator: Thank you all for your patience. The conference call titled Amneal Pharmaceuticals, Inc. Fourth Quarter and Full Year 2025 Earnings Call will begin shortly. During the presentation, you will have the opportunity to ask a question by call. Good morning, and welcome to the...
